MYCi361
MYCi361 is an inhibitor of MYC (binding to MYC with Kd of 3.2 μM) . MYCi361 is a small-molecule MYC inhibitors that inhibits the viability of MYC-dependent cancer cells including prostate cancer (MycCaP, LNCaP, and PC3), leukemia (MV4-11), lymphoma (HL-60 and P493-6), and neuroblastoma (SK-N-B2) with low-micromolar IC50 values.
Product Specifications
CAS Number
2289690-31-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
594.86
Molecular Formula
C26H16ClF9N2O2
Notes
Research use only, not for human use.
Receptor
MYC
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1221498-01 0.02 mg (E-Coli)
Recombinant Rickettsia canadensis Transcription elongation factor GreA (greA)
Sign In for Pricing
View Details MBS1221498-02 0.1 mg (E-Coli)
Recombinant Rickettsia canadensis Transcription elongation factor GreA (greA)
Sign In for Pricing
View Details MBS1221498-03 0.02 mg (Yeast)
Recombinant Rickettsia canadensis Transcription elongation factor GreA (greA)
Sign In for Pricing
View Details MBS1221498-04 0.1 mg (Yeast)
Recombinant Rickettsia canadensis Transcription elongation factor GreA (greA)
Sign In for Pricing
View Details MBS1221498-05 0.02 mg (Baculovirus)
Recombinant Rickettsia canadensis Transcription elongation factor GreA (greA)
Sign In for Pricing
View Details